Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV.

Physical review letters·2001
Same author

Consensus statement of definitions for anorectal physiology and rectal cancer.

ANZ journal of surgery·2001
Same author

Standards in the 21st century. The greening of standardisation.

Medical device technology·2001
Same author

Measurement of the top quark p(T) distribution.

Physical review letters·2001
Same author

IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition.

Oncogene·2001
Same author

Standards in the 21st century. Name that device!

Medical device technology·2001

Related Experiment Video

Updated: Jul 10, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Medical nanotechnology: evolving appropriate risk tools.

R Moore1

  • 1The institute of Nanotechnology, University of Stirling, Stirling, UK. richard.moore@nano.org.uk

Medical Device Technology
|October 18, 2007
PubMed
Summary

This article introduces medical nanotechnology (nanomedicine) and its risk management needs. Further research into nanomedicine risks is recommended for this developing field.

Area of Science:

  • Nanotechnology
  • Medical applications
  • Risk management

Background:

  • Emerging field of medical nanotechnology presents unique challenges.
  • Nanomedicine involves the application of nanotechnology to healthcare.
  • Effective risk management is crucial for nanomedicine's advancement.

Purpose of the Study:

  • To define nanomedicine and its scope.
  • To identify the risk management requirements for medical nanotechnology.
  • To advocate for increased research in nanomedicine risk.

Main Methods:

  • Literature review of current nanomedicine applications.
  • Analysis of existing risk management frameworks.
  • Identification of knowledge gaps in nanomedicine safety.

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Related Experiment Videos

Last Updated: Jul 10, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Main Results:

  • Nanomedicine encompasses diverse applications from diagnostics to therapeutics.
  • Current risk management strategies are insufficient for the complexities of nanomedicine.
  • Significant gaps exist in understanding and mitigating nanomedicine-specific risks.

Conclusions:

  • Medical nanotechnology requires tailored and robust risk management approaches.
  • Further dedicated research into nanomedicine risks is essential.
  • Proactive risk assessment will facilitate the safe and effective translation of nanomedicine into clinical practice.